Illinois officials have added two new qualifying conditions for the state’s medical marijuana program.
The Illinois Department of Public Health (IDPH) announced on Tuesday that patients with sickle cell disease and polyendocrine metabolic ovarian syndrome (PMOS) with chronic pain can now qualify for legal access to medical cannabis, with a doctor’s recommendation.
IDPH Director Dr. Sameer Vohra approved the conditions following a review by the Medical Cannabis Advisory Board.
“Medical cannabis can provide relief for people living with certain debilitating conditions,” he said. “IDPH reviews petitions carefully using expert opinion and the most up to date evidence to make decisions that best serve Illinois residents. We look forward to working with our medical providers to ensure safe, appropriate access for individuals struggling with these newly approved conditions.”
With the two new additions, Illinois now has 58 medical cannabis qualifying conditions.
The move comes about two weeks after the Illinois Department of Financial and Professional Regulation (IDFPR) posted a new form that recreational marijuana dispensaries can file in order to get permission to begin selling medical cannabis, which is taxed at a much lower rate than adult-use products.
The expanded opportunity for marijuana businesses comes as part of omnibus cannabis legislation that was passed by lawmakers and signed into law by Gov. JB Pritzker (D) this session.
The law also doubles the amount of marijuana that adults can legally possess, allows drive-thrus and curbside pickups at dispensaries and lets them stay open for longer hours of operation, among other changes.
“Any adult use dispensary holding an active license in good standing may opt-in for a medical dispensary license,” IDFPR said in previously issued guidance about changes made by the new cannabis omnibus legislation. “This medical dispensary license will allow the dispensary to sell cannabis to medical cannabis patients at the medical tax rate up to the medical patient’s allotment.”
The medical cannabis sales option for adult-use businesses is part of SB 3222, which was approved by the legislature and signed by Pritzker in June.
As enacted into law, the measure also allows residents of the state who are over 21 years of age to possess up to 60 grams of marijuana flower—double the amount in prior law. They are also able to have up to 10 grams of cannabis concentrates and infused products with up to 1,000 mg of THC—also double the earlier limit. Possession amounts for adult non-residents are also doubled under the bill and are generally set at half of what residents can carry.
Additionally, people with past convictions for possession of up to 60 grams of marijuana are now able to have those records expunged—double the previous cutoff allowing only those with convictions for up to 30 grams to be eligible.
The legislation also recriminalizes hemp THC products with more than 0.4 milligrams of THC per container, in line with a federal ban that is set to take effect in November.
The state’s list of medical marijuana qualifying conditions is also being expanded to add female orgasmic disorder, endometriosis, ovarian cysts and uterine fibroids.
The governor held a signing ceremony for the legislation at a marijuana dispensary, saying he is “proud that Illinois continues to lead the nation in showing what thoughtful, balanced cannabis policy can achieve.”
In 2019, Pritzker signed the state’s initial marijuana legalization policy into law.
